Condition
Fetal Aneuploidy
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
Trial Status
Completed1
Recruiting1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT01429389Recruiting
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01555346Completed
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
NCT01404221Terminated
Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications
Showing all 3 trials